P4‐551: VALIDATION OF A NEW ANTIBODY THAT RECOGNIZES A CONFORMATIONAL VARIANT OF P53 SPECIFIC FOR ALZHEIMER'S AT THE PRE‐CLINICAL AND PRODROMAL STAGES OF THE DISEASE. (1st July 2019)